Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Charles River
17 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Biologics Testing Lab
Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource℠ Laboratory
PR-M06-23-01
Preclinical Data
Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data
PAO-05-23-CL-03
Cloud-Based Platform
Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data
PR-M03-23-03
New Drug Development
Venomtech Announces New Drug Development Collaboration with Charles River
PR-M04-22-06
M&A
Charles River Laboratories Completes the Acquisition of HemaCare Corporation
PR-M01-20-NI-005
Microbial
Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio
PR-M09-19-NI-039
Extended Relationship
Charles River Laboratories Announces Extended Relationship with The Michael J. Fox Foundation
PR-M05-18-NI-030
Appointment
Charles River Laboratories Announces Executive Management Appointments
PR-M02-18-NI-58
Acquistion
Charles River Laboratories to Acquire MPI Research
PR-M02-18-NI-57
Investment
Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure
PR-M02-18-NI-017
Appointment
Charles River Laboratories Adds Jean-Paul Mangeolle to Board of Directors
PR-M01-18-NI-064
Acquisition
Charles River Laboratories Continues to Grow Through Acquisition
PAO-M01-18-NI-035
Acquistion
Charles River Laboratories Acquires KWS BioTest
PR-M01-18-NI-040
Immunology
Charles River Laboratories Gains Immunology Contract Research Services
PAO-M01-18-NI-023
CRISPR
Charles River Expands CRISPR Offerings with Second License
PAO-M12-17-NI-022
Acquistion
Brains On-Line Acquired by Charles River Laboratories for $21 million
PAO-M08-17-NI-017
Charles River Announces NCG Mouse Model
PAO-M04-17-NI-007
.svg)
